| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $100.89M | - | |
| Dir | 1.55M | $79.76M | - | |
| Dir | 1.19M | $61.07M | - | |
| CFO | 1.12M | $57.37M | - | |
| VP | 594.7K | $30.54M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 47,500 | $18.09 | $859,275.00 | -10.4% | +2.9% | -7.0% | |
| Nov 1, 2021 | Hessekiel Jeffrey54 | EVP And General Counsel | Sell | 5,117 | $22.03 | $112,727.51 | -0.8% | -16.6% | -22.6% | |
| Oct 15, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 47,500 | $21.92 | $1,041,200.00 | -10.4% | -18.6% | -28.3% | |
| Oct 15, 2021 | Hessekiel Jeffrey54 | EVP And General Counsel | Sell | 12,883 | $22.02 | $283,683.66 | -2.0% | -18.6% | -28.3% | |
| Sep 16, 2021 | Haley Patrick J.56 | EVP, Commercial | Sale+OE | 25,000 | $20.36 | $509,000.00 | -8.2% | -13.0% | -16.5% | |
| Sep 15, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 47,500 | $20.46 | $971,850.00 | -10.9% | -17.0% | -16.3% | |
| Aug 16, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 55,000 | $18.44 | $1,014,200.00 | -12.4% | -2.3% | +5.5% | |
| Jul 15, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 60,000 | $17.47 | $1,048,200.00 | -13.3% | +23.2% | +22.6% | |
| Jun 17, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 60,000 | $22.18 | $1,330,800.00 | -13.3% | -7.5% | -16.1% | |
| May 18, 2021 | Haley Patrick J.56 | EVP, Commercial | Sell | 14,593 | $24.73 | $360,884.89 | -4.9% | -24.0% | -19.9% |